The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy
Open accessAbstract
Mesangial and circulating IgA1 with aberrantly glycosylated hinge region O-glycans characterize IgA nephropathy (IgAN). Unlike healthy individuals, some IgA1 is galactose deficient in patients with IgAN, leaving terminal N-acetylgalactosamine residues in the hinge region exposed. Circulating autoantibodies that recognize such galactose-deficient IgA1 as an autoantigen, or the levels of the autoantigen itself, may allow prediction of disease progression. Here, we analyzed serum samples obtained at diagnosis for autoantigen and autoantibodies from 97 patients with IgAN selected from our prospective cohort according to their absolute renal risk for progression to dialysis or death (0, very low; 1, low; 2, high; 3, very high). We also analyzed samples from controls comprising 30 healthy volunteers and 30 patients with non-IgAN disease. The mean follow-up was 13.8 years. We found that mean serum levels of total autoantigen, normalized IgG autoantibody, and total IgA autoantibody were significantly higher in patients than in the combined controls (all P≤0.01). Furthermore, increasing levels correlated with worse clinical outcomes. In Cox regression and Kaplan-Meier analyses, IgG autoantibody levels ≥1.33 predicted dialysis or death (both P≤0.01). In conclusion, these data suggest that serum levels of IgG and IgA autoantibodies strongly associate with the progression of IgAN nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathophysiology of IgA Nephropathy
Suzuki, H., Kiryluk, K., Novak, J., Moldoveanu, Z., Herr, A. B., Renfrow, M. B., Wyatt, R. J., Scolari, F., Mestecky, J., Gharavi, A. G., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050464 · Cited by 910
Self-citation[Intercapillary deposits of IgA-IgG].
Berger, J., & Hinglais, N. (1968) · PubMed · Cited by 533
Tomana, M., Novak, J., Julian, B. A., Matousovic, K., Konecny, K., & Mestecky, J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5535 · Cited by 498
Self-citationSuzuki, H., Fan, R., Zhang, Z., Brown, R., Hall, S., Julian, B. A., Chatham, W. W., Suzuki, Y., Wyatt, R. J., Moldoveanu, Z., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38468 · Cited by 450
Self-citationPatients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Moldoveanu, Z., Wyatt, R. J., Lee, J. Y., Tomana, M., Julian, B. A., Mestecky, J., Huang, W.-Q., Anreddy, S. R., Hall, S., Hastings, M. C., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002185 · Cited by 422
Self-citationMass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy
Hiki, Y., Odani, H., Takahashi, M., Yasuda, Y., Nishimoto, A., Iwase, H., Shinzato, T., Kobayashi, Y., & Maeda, K. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00591.x · Cited by 378
Predicting the Risk for Dialysis or Death in IgA Nephropathy
Berthoux, F., Mohey, H., Laurent, B., Mariat, C., Afiani, A., & Thibaudin, L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040355 · Cited by 361
Self-citationPencina, M. J., D'Agostino, R. B., & Demler, O. V. (2012) · Statistics in Medicine · doi:10.1002/sim.4348 · Cited by 349
Conley, M. E., Cooper, M. D., & Michael, A. F. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109998 · Cited by 331
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG
Tomana, M., Matoušovic, K., Julian, B. A., Radl, J., Konecný, K., & Mestecky, J. (1997) · Kidney International · doi:10.1038/ki.1997.361 · Cited by 318
Self-citation
Cited by
Wyatt, R. J., & Julian, B. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1206793 · Cited by 1,222
Self-citationTrimarchi, H., Barratt, J., Cattran, D. C., Cook, H. T., Coppo, R., Haas, M., Liu, Z.-H., Roberts, I. S. D., Yuzawa, Y., Zhang, H., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.003 · Cited by 1,192
The immune system and kidney disease: basic concepts and clinical implications
Kurts, C., Panzer, U., Anders, H.-J., & Rees, A. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3523 · Cited by 696
Lai, K. N., Tang, S. C. W., Schena, F. P., Novak, J., Tomino, Y., Fogo, A. B., & Glassock, R. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.1 · Cited by 508
Self-citationFloege, J., & Amann, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00272-5 · Cited by 306
Metadata
- Authors
- Berthoux, F., Suzuki, H., Thibaudin, L., Yanagawa, H., Maillard, N., Mariat, C., Tomino, Y., Julian, B. A., & Novak, J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2012-09
- Volume
- 23
- Issue
- 9
- Pages
- 1579-1587
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2125096231
- Cited by
- 272
- References
- 28
- FWCI
- 12.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy. https://app.cochat.ai/papers/10.1681/asn.2012010053
- The paper
- Berthoux, F., Suzuki, H., Thibaudin, L., Yanagawa, H., Maillard, N., Mariat, C., Tomino, Y., Julian, B. A., & Novak, J. (2012). Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2012010053
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.